What precautions should be taken when using dermal fillers near the supratrochlear and supraorbital arteries?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Supratrochlear and Supraorbital Artery Safety with Dermal Fillers

Avoid deep injections in the glabellar and forehead regions entirely—use only intradermal placement with 30-gauge needles to stay superficial to the supratrochlear and supraorbital arteries, which are the most dangerous vessels for causing retrograde ophthalmic artery embolism and blindness. 1, 2

Critical Vascular Anatomy

The supratrochlear and supraorbital arteries are terminal branches of the ophthalmic artery that supply the forehead and glabellar region. 2, 3 These vessels create a direct pathway to the central retinal artery through their anastomotic connections, making accidental intravascular injection in this area catastrophic—it can cause retrograde embolization leading to permanent blindness. 2, 3

The glabellar and supraorbital regions represent the highest-risk zones for vascular complications during filler injection, with visual alterations being the most severe consequence. 4

Mandatory Injection Technique

Use intradermal placement exclusively—never inject deeply near the supratrochlear or supraorbital arteries. 1

  • Use 30-gauge needles with shallow insertion angles, targeting only the dermis layer. 1, 5
  • Create visible wheals or papules (6-10 mm diameter) to confirm proper intradermal placement—this ensures you remain superficial to major vasculature. 1, 5
  • Inject above the orbicularis oculi muscle to stay superficial to the arterial network. 1
  • Deep injections on the periosteum in the glabellar region directly risk injuring the supratrochlear and supraorbital arteries. 2

Blunt Cannula Alternative

Consider using 22-25 gauge blunt-tip cannulas instead of needles when treating the periorbital and forehead areas, as this provides an additional safety margin. 1

Pre-Injection Safety Protocol

Aspirate before every single injection to detect intravascular needle placement—this is recommended by the American Academy of Dermatology to prevent introducing material directly into vessels. 6, 5

Use incremental small-volume injections (0.2-0.5 mL maximum per site) rather than large boluses to allow early complication detection and minimize vascular compression. 1, 5

Inject in retrograde fashion while withdrawing the needle to further reduce intravascular injection risk. 1

Advanced Precautions

Doppler ultrasound mapping of the supratrochlear and supraorbital arteries before filler injection is recommended for high-risk areas including the glabellar region and forehead. 7 While the American Academy of Dermatology notes that ultrasonographic guidance may not be practical for everyday use by most practitioners, it remains a valuable tool when available. 6

Safer Alternative for High-Risk Patients

Consider autologous platelet concentrates (APCs) instead of hyaluronic acid fillers for periorbital and forehead rejuvenation when volumization is not the primary goal. 1, 8

  • APCs provide skin quality improvement, reduced hyperpigmentation, and wrinkle reduction with lower vascular risk since they are autologous materials. 8
  • Use 30G needles at 0.25 mm depth for intradermal injection in these high-risk areas. 1, 8
  • The limitation is that APCs do not provide lasting volumization (effects last only 3 months), but they offer rejuvenation with potentially lower complication rates. 1, 8

Common Pitfall to Avoid

The most dangerous error is deep periosteal injection in the glabellar region, which places the needle directly in the path of the supratrochlear and supraorbital arteries as they emerge from the orbit. 2, 9 This injection plane must be completely avoided—stay strictly intradermal or consider not treating this area with fillers at all given the catastrophic risk-benefit ratio. 4

References

Guideline

Infraorbital Artery and Dermal Filler Safety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Local Anesthetic Injection Techniques

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Safety and Efficacy of Platelet-Rich Fibrin for Periorbital Rejuvenation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.